These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27095521)

  • 1. 2D-DIGE-based proteomic analysis of intracoronary versus peripheral arterial blood platelets from acute myocardial infarction patients: Upregulation of platelet activation biomarkers at the culprit site.
    Vélez P; Ocaranza-Sánchez R; López-Otero D; Grigorian-Shamagian L; Rosa I; Bravo SB; González-Juanatey JR; García Á
    Proteomics Clin Appl; 2016 Aug; 10(8):851-8. PubMed ID: 27095521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in platelet proteins associated with ST-elevation myocardial infarction: novel clues on pathways underlying platelet activation in acute coronary syndromes.
    Parguiña AF; Grigorian-Shamagian L; Agra RM; López-Otero D; Rosa I; Alonso J; Teijeira-Fernández E; González-Juanatey JR; García Á
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2957-64. PubMed ID: 21921262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of platelet GPVI signaling in ST-elevation myocardial infarction patients demonstrated by a combination of proteomic, biochemical, and functional approaches.
    Vélez P; Ocaranza-Sánchez R; López-Otero D; Grigorian-Shamagian L; Rosa I; Guitián E; García-Acuña JM; González-Juanatey JR; García Á
    Sci Rep; 2016 Dec; 6():39603. PubMed ID: 28004756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a circulating microvesicle protein network involved in ST-elevation myocardial infarction.
    Vélez P; Parguiña AF; Ocaranza-Sánchez R; Grigorian-Shamagian L; Rosa I; Alonso-Orgaz S; de la Cuesta F; Guitián E; Moreu J; Barderas MG; González-Juanatey JR; García Á
    Thromb Haemost; 2014 Oct; 112(4):716-26. PubMed ID: 25007837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary platelet and monocyte activation status within platelet-monocyte complexes are determinants of inflammation in ST elevation myocardial infarction1.
    Majumder B; Koganti S; Lowdell MW; Rakhit RD
    Clin Hemorheol Microcirc; 2016 Nov; 64(1):35-46. PubMed ID: 26890234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteins involved in platelet signaling are differentially regulated in acute coronary syndrome: a proteomic study.
    Parguiña AF; Grigorian-Shamajian L; Agra RM; Teijeira-Fernández E; Rosa I; Alonso J; Viñuela-Roldán JE; Seoane A; González-Juanatey JR; García A
    PLoS One; 2010 Oct; 5(10):e13404. PubMed ID: 20976234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-Derived Protein S100A8/A9 Alters the Platelet Proteome in Acute Myocardial Infarction and Is Associated With Changes in Platelet Reactivity.
    Joshi A; Schmidt LE; Burnap SA; Lu R; Chan MV; Armstrong PC; Baig F; Gutmann C; Willeit P; Santer P; Barwari T; Theofilatos K; Kiechl S; Willeit J; Warner TD; Mathur A; Mayr M
    Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):49-62. PubMed ID: 34809447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local increase in microparticles from the aspirate of culprit coronary arteries in patients with ST-segment elevation myocardial infarction.
    Min PK; Kim JY; Chung KH; Lee BK; Cho M; Lee DL; Hong SY; Choi EY; Yoon YW; Hong BK; Rim SJ; Kwon HM
    Atherosclerosis; 2013 Apr; 227(2):323-8. PubMed ID: 23422831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent enhanced platelet activation in patients with acute myocardial infarction and coronary microvascular obstruction: clinical implications.
    Aurigemma C; Scalone G; Tomai F; Altamura L; De Persio G; Stazi A; Lanza GA; Crea F
    Thromb Haemost; 2014 Jan; 111(1):122-30. PubMed ID: 24085158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in thrombus composition and profilin-1 release in acute myocardial infarction.
    Ramaiola I; Padró T; Peña E; Juan-Babot O; Cubedo J; Martin-Yuste V; Sabate M; Badimon L
    Eur Heart J; 2015 Apr; 36(16):965-75. PubMed ID: 25217443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering acute coronary syndrome biomarkers: High-resolution proteomics in platelets, thrombi and microparticles.
    Navas-Carrillo D; Marín F; Valdés M; Orenes-Piñero E
    Crit Rev Clin Lab Sci; 2017 Jan; 54(1):49-58. PubMed ID: 28013562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention.
    Porto I; Biasucci LM; De Maria GL; Leone AM; Niccoli G; Burzotta F; Trani C; Tritarelli A; Vergallo R; Liuzzo G; Crea F
    Eur Heart J; 2012 Dec; 33(23):2928-38. PubMed ID: 22453653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 2D-DIGE-based proteomic analysis reveals differences in the platelet releasate composition when comparing thrombin and collagen stimulations.
    Vélez P; Izquierdo I; Rosa I; García Á
    Sci Rep; 2015 Feb; 5():8198. PubMed ID: 25645904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A detailed proteomic analysis of rhodocytin-activated platelets reveals novel clues on the CLEC-2 signalosome: implications for CLEC-2 signaling regulation.
    Parguiña AF; Alonso J; Rosa I; Vélez P; González-López MJ; Guitián E; Eble JA; Loza MI; García Á
    Blood; 2012 Dec; 120(26):e117-26. PubMed ID: 23053573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute ST-segment elevation myocardial infarction.
    Madder RD; Goldstein JA; Madden SP; Puri R; Wolski K; Hendricks M; Sum ST; Kini A; Sharma S; Rizik D; Brilakis ES; Shunk KA; Petersen J; Weisz G; Virmani R; Nicholls SJ; Maehara A; Mintz GS; Stone GW; Muller JE
    JACC Cardiovasc Interv; 2013 Aug; 6(8):838-46. PubMed ID: 23871513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic characterization of human coronary thrombus in patients with ST-segment elevation acute myocardial infarction.
    Alonso-Orgaz S; Moreno-Luna R; López JA; Gil-Dones F; Padial LR; Moreu J; de la Cuesta F; Barderas MG
    J Proteomics; 2014 Sep; 109():368-81. PubMed ID: 25065646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary eptifibatide bolus administration during percutaneous coronary revascularization for acute coronary syndromes with evaluation of platelet glycoprotein IIb/IIIa receptor occupancy and platelet function: the Intracoronary Eptifibatide (ICE) Trial.
    Deibele AJ; Jennings LK; Tcheng JE; Neva C; Earhart AD; Gibson CM
    Circulation; 2010 Feb; 121(6):784-91. PubMed ID: 20124127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An increased platelet-leukocytes interaction at the culprit site of coronary artery occlusion in acute myocardial infarction: a pathogenic role for "no-reflow" phenomenon?
    Botto N; Sbrana S; Trianni G; Andreassi MG; Ravani M; Rizza A; Al-Jabri A; Palmieri C; Berti S
    Int J Cardiol; 2007 Apr; 117(1):123-30. PubMed ID: 16890311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calreticulin-independent regulation of the platelet integrin alphaIIbbeta3 by the KVGFFKR alphaIIb-cytoplasmic motif.
    Reilly D; Larkin D; Devocelle M; Fitzgerald DJ; Moran N
    Platelets; 2004 Feb; 15(1):43-54. PubMed ID: 14985176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, randomized, prospective comparison of loading doses of 600 mg clopidogrel versus 60 mg prasugrel in patients with acute ST-segment elevation myocardial infarction scheduled for primary percutaneous intervention: the ETAMI trial (early thienopyridine treatment to improve primary PCI in patients with acute myocardial infarction).
    Zeymer U; Mochmann HC; Mark B; Arntz HR; Thiele H; Diller F; Montalescot G; Zahn R
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):147-154. PubMed ID: 25616919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.